Free
Globally, innovators are finding the need for speed as the driver for investment, partnering and success: speed to the clinic, speed to early human data, and speed to de-risk assets. The question for European biotechs is what's their best strategy to compete in this arena, facing new momentum from Asia, and an unpredictable landscape in the U.S. As always, the science in Europe is there. There are more experienced operators than ever before. And after four long years, investor sentiment, finally, is turning.
In its 26th edition, Bio€quity Europe travels to Central and Eastern Europe for the first time to explore opportunities in the region, and to debate how European biotech can accelerate to compete — and lead — in today's world.
Why attend?
- Debate what is next for the European biotech ecosystem
- Meet VCs, CEOs and BD&L leaders in an intimate setting designed for networking and discussion
- Discover 100+ emerging biotechs selected for the Presenting Company Track
- Schedule partnering meetings with investors and pharma BD&L
- Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company
Exclusive discount for BIA members
If you would like to receive the discount code, please email [email protected]
